Use of SCF and G-CSF in the Treatment of Cerebral Ischemia and Neurological Disorders

The present invention relates to the use of stem cell factor (SCF) polypeptide, alone and in combination with granulocyte colony stimulating factor (G-CSF) polypeptide, in the prevention or treatment of injury to the brain after cerebral ischemia or neurological disorder. More particularly, the invention provides methods of improving neurological function and outcome after stroke by the administration of SCF polypeptide, alone and in combination with G-CSF polypeptide. This treatment can be used alone or in combination with other well-known methods of treatment of cerebral ischemia and neurological disorders in a mammal.

Patents:
US 20,100,286,039

Inventor(s): ZHAO LI-RU [US]; KESSLER JOHN [US]; SINGHAL SEEMA [US]; MEHTA JAYESH [US]

Type of Offer: Licensing



« More Medical Patents

---